BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 20061949)

  • 1. Transgenic pigs for xenotransplantation: selection of promoter sequences for reliable transgene expression.
    Aigner B; Klymiuk N; Wolf E
    Curr Opin Organ Transplant; 2010 Apr; 15(2):201-6. PubMed ID: 20061949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic modification of pigs as organ donors for xenotransplantation.
    Klymiuk N; Aigner B; Brem G; Wolf E
    Mol Reprod Dev; 2010 Mar; 77(3):209-21. PubMed ID: 19998476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xenotransplantation of solid organs in the pig-to-primate model.
    Ekser B; Rigotti P; Gridelli B; Cooper DK
    Transpl Immunol; 2009 Jun; 21(2):87-92. PubMed ID: 18955143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Xenotransplantation.
    Schneider MK
    Curr Opin Organ Transplant; 2010 Apr; 15(2):200. PubMed ID: 20110813
    [No Abstract]   [Full Text] [Related]  

  • 5. [Transgenic pigs for xenotransplantation for humans].
    Niemann H
    Dtsch Tierarztl Wochenschr; 1999 Apr; 106(4):141-6. PubMed ID: 10354642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulatory and inhibitory receptor interactions in xenotransplantation.
    Plege A; Schwinzer R
    Curr Opin Organ Transplant; 2010 Apr; 15(2):219-23. PubMed ID: 20075730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of hyperacute rejection in a model of orthotopic liver xenotransplantation from pig to baboon using polytransgenic pig livers (CD55, CD59, and H-transferase).
    Ramírez P; Montoya MJ; Ríos A; García Palenciano C; Majado M; Chávez R; Muñoz A; Fernández OM; Sánchez A; Segura B; Sansano T; Acosta F; Robles R; Sánchez F; Fuente T; Cascales P; González F; Ruiz D; Martínez L; Pons JA; Rodríguez JI; Yélamos J; Cowan P; d'Apice A; Parrilla P
    Transplant Proc; 2005 Nov; 37(9):4103-6. PubMed ID: 16386637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beyond hyperacute rejection: strategies for development of pig-->primate xenotransplantation.
    Hancock WW
    Kidney Int Suppl; 1997 Mar; 58():S36-40. PubMed ID: 9067940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of delayed rejection in transgenic pig-to-primate cardiac xenotransplantation.
    Chen RH; Kadner A; Mitchell RN; Adams DH
    J Surg Res; 2000 May; 90(2):119-25. PubMed ID: 10792951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human DAF on pig cells protects against human and non-human primate sera cytotoxicity mediated by exogenous or endogenous complement, as determined by flow cytometry.
    Díaz-Román TM; Mañez R; López-Pelaez E; Centeno A; Moscoso I; Pértegaz S; Doménech N
    Transpl Immunol; 2006 Aug; 16(2):125-30. PubMed ID: 16860716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a CD46 transgenic pig and protection of transgenic kidneys against hyperacute rejection in non-immunosuppressed baboons.
    Loveland BE; Milland J; Kyriakou P; Thorley BR; Christiansen D; Lanteri MB; Regensburg M; Duffield M; French AJ; Williams L; Baker L; Brandon MR; Xing PX; Kahn D; McKenzie IF
    Xenotransplantation; 2004 Mar; 11(2):171-83. PubMed ID: 14962279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress in xenotransplantation.
    Cozzi E; Masroor S; Soin B; Vial C; White DJ
    Clin Nephrol; 2000 Apr; 53(4):suppl 13-8. PubMed ID: 10809429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The study of mitoxantrone as a potential immunosuppressor in transgenic pig renal xenotransplantation in baboons: comparison with cyclophosphamide.
    Ashton-Chess J; Meurette G; Karam G; Petzold T; Minault D; Naulet J; Tesson L; Plat M; Anegon I; Soulillou JP; Blancho G
    Xenotransplantation; 2004 Mar; 11(2):112-22. PubMed ID: 14962273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune responses to alpha1,3 galactosyltransferase knockout pigs.
    Puga Yung G; Schneider MK; Seebach JD
    Curr Opin Organ Transplant; 2009 Apr; 14(2):154-60. PubMed ID: 19300259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Critical issues related to porcine xenograft exposure to human viruses: lessons from allotransplantation.
    Millard AL; Mueller NJ
    Curr Opin Organ Transplant; 2010 Apr; 15(2):230-5. PubMed ID: 20061950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transgenic pigs expressing human decay-accelerating factor regulated by porcine MCP gene promoter.
    Murakami H; Nagashima H; Takahagi Y; Miyagawa S; Fujimura T; Toyomura K; Nakai R; Yamada M; Kurihara T; Shigehisa T; Okabe M; Seya T; Shirakura R; Kinoshita T
    Mol Reprod Dev; 2002 Mar; 61(3):302-11. PubMed ID: 11835575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Xenotransplantation: physiopathology of hyperacute and differentiated rejection, and therapeutic perspectives].
    Malassagne B; Calmus Y; Houssin D; Weill B
    Pathol Biol (Paris); 2000 May; 48(4):377-82. PubMed ID: 10868402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The perspectives for porcine-to-human xenografts.
    Petersen B; Carnwath JW; Niemann H
    Comp Immunol Microbiol Infect Dis; 2009 Mar; 32(2):91-105. PubMed ID: 18280567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coagulation dysregulation as a barrier to xenotransplantation in the primate.
    Lin CC; Cooper DK; Dorling A
    Transpl Immunol; 2009 Jun; 21(2):75-80. PubMed ID: 19000927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue expression of human complement inhibitor, decay-accelerating factor, in transgenic pigs. A potential approach for preventing xenograft rejection.
    Rosengard AM; Cary NR; Langford GA; Tucker AW; Wallwork J; White DJ
    Transplantation; 1995 May; 59(9):1325-33. PubMed ID: 7539168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.